サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1761169

In-Vitro肺モデル市場規模と予測 2021年～2031年、世界と地域のシェア、動向、成長機会分析レポート：タイプ別、用途別、エンドユーザー別、地域別

In Vitro Lung Models Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, End User, and Geography

出版日
ページ情報
英文 231 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.09円
In-Vitro肺モデル市場規模と予測 2021年～2031年、世界と地域のシェア、動向、成長機会分析レポート：タイプ別、用途別、エンドユーザー別、地域別
出版日: 2025年06月11日
発行: The Insight Partners
ページ情報: 英文 231 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

In-Vitro肺モデル市場規模は、2024年の4億4,635万米ドルから2031年には15億3,011万米ドルに達すると予測されています。同市場は、2025～2031年の間にCAGR 19.4％を記録すると推定されます。市場成長を促進する主な要因としては、呼吸器疾患の急増、動物実験に代わるIn-Vitro肺モデルの採用増加などが挙げられます。さらに、腫瘍学における3D培養とAIの応用は、予測期間中に市場を押し上げる可能性が高いです。しかし、熟練した専門家の不足は市場の抑制要因の一つです。

Global Initiative on Chronic Obstructive Lung Disease（慢性閉塞性肺疾患に関する世界・イニシアティブ）が発表した報告書によると、閉塞性肺疾患（COPD）に罹患している人は6,500万人に上り、毎年300万人近くがこの疾患で死亡しており、世界第4位の死亡原因となっています。2023年のアメリカ肺協会のデータによると、～3,400万人のアメリカ人が喘息やCOPDなどの慢性肺疾患に罹患しています。2022年には、米国の人口の4.6％にあたる～1,170万人の成人がCOPDと診断されました。2020年にEuropean Respiratory Journalに掲載された論文によると、3,658万人の欧州人がCOPDに罹患していると報告されており、2050年には4,945万人に達すると予測されており、相対的に35.2％増加することになります。発展途上諸国での喫煙の普及と高所得諸国での高齢化に伴い、COPD有病率は今後40年間で上昇すると予測されています。世界保健機関（WHO）の推計によると、COPDは2030年までに世界の主要な死因のひとつとなり、2060年までにCOPDおよび関連疾患による死亡者は年間540万人を超えると推定されています。

そのため、呼吸器疾患は、疾患のメカニズムを理解し、効果的な治療法を開発するための高度な研究モデルの需要に拍車をかけています。

精密切断肺スライス（PCLS）のような試験管内肺モデルは、気道収縮や炎症の研究を可能にし、喘息やその他の呼吸器疾患に対する新規治療標的の評価を容易にします。ラングオンチップは、ヒトの肺の生理的状態を再現するために開発されました。ミシガン大学の"lung-on-a-chip "デバイスは、微細な流路を持つプラスチックチップ上で培養したヒト肺組織細胞を用いて肺の中の状態をシミュレートし、疾患に対する新たな知見を提供するものです。このように、効果的な治療や研究モデルに対する需要の高まりが、試験管内肺モデル市場の成長を後押ししています。

さらに、二次元（2D）細胞培養や単層培養は、費用対効果が高く、スループットが高く、複製が容易で、結果の解釈がしやすいため、細胞生物学において疾患の研究や薬剤スクリーニングに広く用いられています。しかしながら、生きた患者の腫瘍の3次元腫瘍微小環境（TME）に存在する動的相互作用の複雑なネットワークを再現するには不十分です。この側面は、がんの挙動や薬物反応をモデル化したり、患者の生検からがん細胞株を分離して2次元培養で維持したりする能力を制限しています。従来の2次元細胞培養は基礎的なものではあるが、in vivoでの肺がんを特徴づける複雑なTMEと細胞相互作用を再現するには不十分です。がん研究が進歩するにつれ、動物モデルの作成に利用される動物の数も増えています。これらの動物にはマウス、ラット、その他の類似種が含まれます。しかしながら、動物モデルは前臨床試験で得られた知見を効果的な臨床治療に結びつける成功率が低いです。このような限界に対処するため、研究はより生理学的に適切なヒトIn-Vitroモデル（3D細胞培養モデル）-スフェロイド、オルガノイド、腫瘍細胞、マイクロ流体システムなど-に移行しつつあり、これらは臨床で観察されるTME、遺伝子発現、薬物応答をよりよく模倣しています。これらのモデルは、特に肺がん研究において、薬剤の有効性を検証し、前臨床試験を改善するために不可欠です。薬剤スクリーニングにおける3Dモデルの統合は、2D培養から得られた知見を検証し、抗がん剤の効果を評価するために不可欠です。このようなアプローチは、がん治療薬のスクリーニングに有益であることが証明されており、肺がん研究と治療開発の将来を形作る極めて重要なツールとして台頭してきています。肺がん薬理学研究における3D細胞培養モデルの使用は、肺疾患の理解と治療に対するアプローチのパラダイムシフトを意味します。

競合企業別分析では、製品ポートフォリオ（製品満足度、製品の特徴、入手可能性）、最近の市場動向（合併・買収、新製品の上市・強化、投資・資金調達、受賞、合意、提携・協力、認知、拡大）、競合情勢のより良い意思決定と理解を助ける地理的プレゼンスに基づいて、試験管内肺モデル市場を評価・分類しています。本レポートでは、世界の試験管内肺モデル市場における主要ベンダーの最近の重要な動向と革新について深く調査しています。主な市場企業は、MatTek Corp、Lonza Group AG、Emulate, Inc、CN Bio Innovations Ltd、PromoCell GmbH、Charles River Laboratories International Inc、MIMETAS BV、InSphero AG、Organovo Holdings Inc、Draper, Inc、Epithelix、AlveoliX AG、American Type Culture Collection（ATCC）です。

タイプによって、市場は3Dモデルと2Dモデルに分けられます。3Dモデルは、2024年にIn-Vitro肺モデル市場で最大のシェアを占め、2024～2031年に最も高いCAGRを記録すると予測されています。

3D肺モデルは、ヒト肺組織の複雑な構造と細胞相互作用を正確に再現しています。生理学的な関連性が強化されているため、創薬、毒性試験、疾患モデリングに非常に有用です。3D肺モデルの主な種類には、スフェロイド、オルガノイド、精密切断肺スライス（PCLS）などがあります。3Dモデルでは、細胞は3次元構造内で培養されるため、従来の2Dモデルにはない利点があります。これらのモデルは、肺の構造や微小環境を忠実に再現しており、生理学的条件の正確なシミュレーションが可能です。その結果、3Dモデルを用いた薬物・治療研究は、2Dモデルや動物モデルから得られた結果よりも正確で信頼性の高い結果をもたらす傾向があります。

In-Vitro肺モデル市場は用途別に、創薬・毒性研究、生理学的研究、再生医療、その他に区分されます。2024年のIn-Vitro肺モデル市場では、創薬・毒性研究分野が最大のシェアを占めています。

エンドユーザー別では、In-Vitro肺モデル市場は製薬・バイオテクノロジー企業、学術・研究機関、その他に区分されます。2024年のIn-Vitro肺モデル市場では、製薬・バイオ企業セグメントが最大シェアを占めています。

In-Vitro肺モデル市場で事業を展開する企業は、さまざまな有機的・無機的戦略を採用しています。有機的戦略には、主に製品上市と製品承認が含まれます。市場で見られる無機的な成長戦略は、買収、提携、パートナーシップです。これらの成長戦略により、市場参入企業は事業を拡大し、地理的プレゼンスを高めるとともに、市場全体の成長に貢献することができます。さらに、買収や提携などの戦略は、顧客基盤を強化し、製品ポートフォリオを拡大するのに役立っています。試験管内肺モデル市場の主要企業による重要な発展の一部を以下に示します。

2024年9月、試験管内ヒト組織の開発を専門とするバイオテクノロジー企業であるMatTek Life Sciences社は、中国を拠点とするライフサイエンス研究所であるCellEx社に同社の器官型ヒト組織をライセンシングすることを発表しました。この戦略的提携は、研究開発、医薬品開発、安全性評価用途におけるヒト組織の進歩と利用における画期的な出来事です。

2023年6月、次世代in vitroモデルのプロバイダーであるエミュレート社は、早期アクセスプログラムを通じてEmulate Chip-A1 Accessible Chipの発売を発表しました。この新しいOrgan-Chipのデザインは、ストレッチやフローといった生体力学的な力を用いて組織と血管のインターフェイスをモデル化したオリジナルのChip-S1を拡張したもので、ユーザーは上皮培養チャンバー内でより厚い組織を作製し、局所投与やエアロゾル化などの薬物治療のオプションを追加することができます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • アナリスト市場の展望

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ
  • 仮定と限界

第4章 In-Vitro肺モデル市場情勢

  • PEST分析
  • 規制シナリオ

第5章 In-Vitro肺モデル市場：主要市場力学

  • In-Vitro肺モデル市場- 主な市場力学
  • 市場促進要因
    • 呼吸器疾患の急増
    • 動物実験の代替としてのIn-Vitroモデルの採用増加
  • 市場抑制要因
    • 熟練専門家の不足
  • 市場機会
    • In-Vitroモデルに対する資金調達と投資の急増
  • 今後の動向
    • 腫瘍学における3D培養とAIの応用
  • 促進要因と抑制要因の影響

第6章 In-Vitro肺モデル市場：世界市場分析

  • In-Vitro肺モデル市場収益、2021-2031年
  • In-Vitro肺モデル市場予測分析

第7章 In-Vitro肺モデル市場分析-タイプ別

  • 3Dモデル
  • 2Dモデル

第8章 In-Vitro肺モデル市場分析-用途別

  • 創薬・毒性研究
  • 生理学研究
  • 再生医療
  • その他

第9章 In-Vitro肺モデル市場分析-エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 学術・研究機関
  • その他

第10章 In-Vitro肺モデル市場- 地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • アジア太平洋地域のその他諸国
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • その他中東とアフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第11章 業界情勢

  • 新製品開発
  • 合併と買収
  • パートナーシップと提携
  • その他の事業戦略

第12章 競合情勢

  • 世界企業シェア分析、2024年

第13章 企業プロファイル

  • MatTek Corp
  • Lonza Group AG
  • Emulate, Inc.
  • CN Bio Innovations Ltd
  • Merck KGaA
  • PromoCell GmbH
  • Charles River Laboratories International Inc
  • MIMETAS BV
  • InSphero AG
  • Organovo Holdings Inc
  • Draper, Inc.
  • TissUse GmbH
  • Epithelix
  • AlveoliX AG
  • American Type Culture Collection（ATCC）

第14章 付録

図表

List Of Tables

  • Table 1. In-Vitro Lung Model Market Segmentation
  • Table 2. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million)
  • Table 3. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million)
  • Table 4. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 5. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 6. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 7. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 8. In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 9. In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 10. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 11. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 12. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 13. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 14. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 15. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 16. North America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 17. North America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 18. United States: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 19. United States: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 20. United States: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 21. United States: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 22. United States: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 23. United States: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 24. Canada: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 25. Canada: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 26. Canada: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 27. Canada: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 28. Mexico: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 29. Mexico: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 30. Mexico: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 31. Mexico: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 32. Mexico: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 33. Mexico: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 34. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 35. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 36. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 37. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 38. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 39. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 40. Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 41. Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 42. Germany: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 43. Germany: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 44. Germany: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 45. Germany: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 46. Germany: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 47. Germany: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 48. France: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 49. France: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 50. France: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 51. France: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 52. France: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 53. France: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 54. United Kingdom: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 55. United Kingdom: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 56. United Kingdom: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 57. United Kingdom: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 58. United Kingdom: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 59. United Kingdom: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 60. Italy: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 61. Italy: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 62. Italy: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 63. Italy: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 64. Italy: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 65. Italy: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 66. Spain: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 67. Spain: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 68. Spain: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 69. Spain: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 70. Spain: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 71. Spain: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 72. Rest of Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 73. Rest of Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 74. Rest of Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 75. Rest of Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 76. Rest of Europe: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 77. Rest of Europe: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 78. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 79. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 80. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 81. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 82. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 83. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 84. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 85. Asia Pacific: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 86. China: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 87. China: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 88. China: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 89. China: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 90. China: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 91. China: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 92. Japan: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 93. Japan: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 94. Japan: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 95. Japan: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 96. Japan: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 97. Japan: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 98. India: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 99. India: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 100. India: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 101. India: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 102. India: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 103. India: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 104. South Korea: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 105. South Korea: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 106. South Korea: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 107. South Korea: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 108. South Korea: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 109. South Korea: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 110. Australia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 111. Australia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 112. Australia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 113. Australia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 114. Australia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 115. Australia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 116. Rest of APAC: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 117. Rest of APAC: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 118. Rest of APAC: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 119. Rest of APAC: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 120. Rest of APAC: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 121. Rest of APAC: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 122. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 123. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 124. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 125. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 126. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 127. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 128. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 129. Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 130. Saudi Arabia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 131. Saudi Arabia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 132. Saudi Arabia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 133. Saudi Arabia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 134. Saudi Arabia: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 135. Saudi Arabia: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 136. South Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 137. South Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 138. South Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 139. South Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 140. South Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 141. South Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 142. United Arab Emirates: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 143. United Arab Emirates: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 144. United Arab Emirates: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 145. United Arab Emirates: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 146. United Arab Emirates: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 147. United Arab Emirates: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 148. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 149. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 150. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 151. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 152. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 153. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 154. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 155. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 156. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 157. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 158. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 159. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 160. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 161. South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 162. Brazil: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 163. Brazil: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 164. Brazil: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 165. Brazil: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 166. Brazil: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 167. Brazil: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 168. Argentina: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 169. Argentina: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 170. Argentina: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 171. Argentina: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 172. Argentina: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 173. Argentina: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 174. Rest of South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Type
  • Table 175. Rest of South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Type
  • Table 176. Rest of South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 177. Rest of South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 178. Rest of South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 179. Rest of South and Central America: In-Vitro Lung Model Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 180. Glossary of Terms, In-Vitro Lung Model Market

List Of Figures

  • Figure 1. In-Vitro Lung Model Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. In-Vitro Lung Model Market Revenue (US$ Million), 2021-2031
  • Figure 5. In-Vitro Lung Model Market Share (%) - by Type (2024 and 2031)
  • Figure 6. 3D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. 2D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. In-Vitro Lung Model Market Share (%) - by Application (2024 and 2031)
  • Figure 9. Drug Discovery and Toxicology Studies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Physiological Research: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Regenerative Medicine: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. In-Vitro Lung Model Market Share (%) - by End User (2024 and 2031)
  • Figure 14. Pharmaceutical and Biotechnology Companies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Academic and Research Institutes: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. In-Vitro Lung Model Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 18. North America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 19. North America: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 20. North America: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 21. North America: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
  • Figure 22. North America: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 23. United States: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Canada: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 25. Mexico: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Europe: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 27. Europe: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 28. Europe: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 29. Europe: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
  • Figure 30. Europe: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 31. Germany: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. France: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. United Kingdom: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. Italy: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Spain: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 36. Rest of Europe: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 37. Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 38. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 39. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 40. Asia Pacific: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 41. China: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 42. Japan: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 43. India: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 44. South Korea: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 45. Australia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 46. Rest of APAC: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 48. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 49. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 50. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
  • Figure 51. Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 52. Saudi Arabia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 53. South Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 54. United Arab Emirates: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 55. Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 56. South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
  • Figure 57. South and Central America: In-Vitro Lung Model Market Breakdown, by Type (2024 and 2031)
  • Figure 58. South and Central America: In-Vitro Lung Model Market Breakdown, by Application (2024 and 2031)
  • Figure 59. South and Central America: In-Vitro Lung Model Market Breakdown, by End User (2024 and 2031)
  • Figure 60. South and Central America: In-Vitro Lung Model Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 61. Brazil: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 62. Argentina: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 63. Rest of South and Central America: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 64. Global Company Market Share Analysis, 2024
目次
Product Code: TIPRE00006695

The In Vitro lung models market size is projected to reach US$ 1,530.11 million by 2031 from US$ 446.35 million in 2024. The market is estimated to register a CAGR of 19.4% during 2025-2031. Major factors driving the market growth include a surging prevalence of respiratory diseases and the rising adoption of in vitro models as an alternative to animal testing. Further, Applications of 3D cultures and AI in oncology is likely to boost the market during the forecast period. However, lack of skilled professionals are among the market deterrents.

According to a report published by the Global Initiative on Chronic Obstructive Lung Disease, ~65 million people suffer from obstructive pulmonary disease (COPD), and nearly 3 million people die from the disease each year, making it the fourth leading cause of mortality worldwide. According to the 2023 American Lung Association data, ~34 million Americans were affected by chronic lung diseases such as asthma and COPD. In 2022, ~11.7 million adults, or 4.6% of the population in the US, were diagnosed with COPD. As per an article published in the European Respiratory Journal in 2020, 36.58 million Europeans were reported to have COPD, which is projected to reach 49.45 million by 2050, representing a 35.2% relative increase. With the growing prevalence of smoking in developing countries and the aging population in high-income countries, the COPD prevalence is projected to rise over the next forty years. As per the World Health Organization (WHO) estimates, COPD will become one of the leading causes of death worldwide by 2030, and it is estimated that by 2060, there will be more than 5.4 million deaths yearly due to COPD and related conditions.

Therefore, respiratory diseases is spurring the demand for advanced research models to understand disease mechanisms and develop effective treatments.

In vitro lung models, such as precision-cut lung slices (PCLS), allow the study of airway constriction and inflammation, facilitating the evaluation of novel therapeutic targets for asthma and other respiratory conditions. Lung-on-a-chip devices have been developed to replicate the physiological conditions of the human lung. The University of Michigan's "lung-on-a-chip" device uses human lung-tissue cells cultured on a plastic chip with microscopic channels to simulate the conditions inside the lungs, providing new insights into diseases. Thus, the increasing demand for effective treatments and research models fuels the growth of the in vitro lung model market.

Moreover, two-dimensional (2D) cell cultures, or monolayers, are widely used in cellular biology to study diseases and for drug screening due to their cost-effectiveness, high throughput, easy replication, and results interpretation. However, they fall short in replicating the complex network of dynamic interactions present in the three-dimensional tumor microenvironment (TME) of living patient tumors. This aspect limits their ability to model cancer behavior and drug responses, as well as to isolate and maintain cancer cell lines from patient biopsies in 2D cultures. Traditional 2D cell cultures, while foundational, fall short in replicating the intricate TME and cellular interactions that characterize lung cancers in vivo. As cancer research advances, an increasing number of animals are being utilized in the creation of animal models. These animals include mice, rats, and other similar species. However, animal models exhibit low success rates in translating preclinical findings into effective clinical treatments; this has raised concerns about their reliability as predictors of human responses. To address these limitations, research is shifting toward more physiologically relevant human in vitro models (3D cell culture models)-such as spheroids, organoids, tumoroids, and microfluidic systems-that better mimic the TME, gene expression, and drug responses observed clinically. These models are critical for validating drug efficacy and improving preclinical testing, especially in lung cancer research. Integrating 3D models in drug screening is essential to validate findings from 2D cultures and assess the effects of anticancer drugs. Such approaches have proven to be fruitful for cancer drug screening and are emerging as a pivotal tool in shaping the future of lung cancer research and therapeutic development. The use of 3D cell culture models in lung cancer pharmacology research represents a paradigm shift in the approach toward understanding and treating lung diseases.

The comparative company analysis evaluates and categorizes the in vitro lung models market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global in vitro lung models market. The key market players are MatTek Corp, Lonza Group AG, Emulate, Inc, CN Bio Innovations Ltd, PromoCell GmbH, Charles River Laboratories International Inc, MIMETAS BV, InSphero AG, Organovo Holdings Inc, Draper, Inc, Epithelix, AlveoliX AG, and American Type Culture Collection (ATCC).

Based on type, the market is divided into 3D Models and 2D Models. The 3D Models segment held the largest In Vitro Lung Model Market share in 2024, and it is expected to register the highest CAGR during 2024-2031.

3D lung models replicate the complex architecture and cellular interactions of human lung tissue accurately. The enhanced physiological relevance makes them invaluable for drug discovery, toxicity testing, and disease modeling. The primary types of 3D lung models include spheroids, organoids, and precision-cut lung slices (PCLS). In 3D models, cells are cultured within a three-dimensional structure, offering advantages over traditional 2D models. These models closely replicate the architecture and microenvironment of the lung, enabling accurate simulation of physiological conditions. As a result, drug and therapeutic studies using 3D models tend to yield more accurate and reliable results than those derived from 2D models or animal models.

By application, In Vitro Lung Model market is segmented into drug discovery and toxicology studies, physiological research, regenerative medicine, and others. The drug discovery and toxicology studies segment held the largest share of the in vitro lung model market in 2024.

Per end user, In Vitro Lung Model market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and others. The pharmaceutical and biotechnology companies segment held the largest share of the In Vitro lung model market in 2024.

Various organic and inorganic strategies are adopted by companies operating in the in vitro lung models market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the in vitro lung models market are listed below.

In September 2024, MatTek Life Sciences, a biotech company specializing in the development of in vitro human tissues, announced the licensing of its organotypic human tissues to CellEx, a life science laboratory based in China. This strategic collaboration marks a milestone in the advancement and utilization of human tissues for research, pharmaceutical development, and safety assessment applications.

In June 2023, Emulate, Inc., a provider of next-generation in vitro models, announced the launch of the Emulate Chip-A1 Accessible Chip through an early access program. This new Organ-Chip design expands on the original Chip-S1-which models tissue-vascular interfaces with relevant biomechanical forces such as stretch and flow-by allowing users to create thicker tissues within the epithelial culture chamber and apply additional drug treatment options, including topical or aerosolized applications.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. In-Vitro Lung Model Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Regulatory Scenario

5. In-Vitro Lung Model Market - Key Market Dynamics

  • 5.1 In-Vitro Lung Model Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Surging Prevalence of Respiratory Diseases
    • 5.2.2 Rising Adoption of In Vitro Models as an Alternative to Animal Testing
  • 5.3 Market Restraints
    • 5.3.1 Lack of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Surging Funding and Investments for In Vitro Models
  • 5.5 Future Trends
    • 5.5.1 Application of 3D Cultures and AI in Oncology
  • 5.6 Impact of Drivers and Restraints:

6. In-Vitro Lung Model Market - Global Market Analysis

  • 6.1 In-Vitro Lung Model Market Revenue (US$ Million), 2021-2031
  • 6.2 In-Vitro Lung Model Market Forecast Analysis

7. In-Vitro Lung Model Market Analysis - by Type

  • 7.1 3D Model
    • 7.1.1 Overview
    • 7.1.2 3D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 2D Model
    • 7.2.1 Overview
    • 7.2.2 2D Model: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)

8. In-Vitro Lung Model Market Analysis - by Application

  • 8.1 Drug Discovery and Toxicology Studies
    • 8.1.1 Overview
    • 8.1.2 Drug Discovery and Toxicology Studies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Physiological Research
    • 8.2.1 Overview
    • 8.2.2 Physiological Research: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Regenerative Medicine
    • 8.3.1 Overview
    • 8.3.2 Regenerative Medicine: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)

9. In-Vitro Lung Model Market Analysis - by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Overview
    • 9.1.2 Pharmaceutical and Biotechnology Companies: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Academic and Research Institutes
    • 9.2.1 Overview
    • 9.2.2 Academic and Research Institutes: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: In-Vitro Lung Model Market - Revenue and Forecast to 2031 (US$ Million)

10. In-Vitro Lung Model Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America In-Vitro Lung Model Market Overview
    • 10.2.2 North America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.2.3 North America: In-Vitro Lung Model Market Breakdown, by Type
      • 10.2.3.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.2.4 North America: In-Vitro Lung Model Market Breakdown, by Application
      • 10.2.4.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
    • 10.2.5 North America: In-Vitro Lung Model Market Breakdown, by End User
      • 10.2.5.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.2.6 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.1 North America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.2 United States: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.2.1 United States: In-Vitro Lung Model Market Breakdown, by Type
        • 10.2.6.2.2 United States: In-Vitro Lung Model Market Breakdown, by Application
        • 10.2.6.2.3 United States: In-Vitro Lung Model Market Breakdown, by End User
      • 10.2.6.3 Canada: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.3.1 Canada: In-Vitro Lung Model Market Breakdown, by Type
        • 10.2.6.3.2 Canada: In-Vitro Lung Model Market Breakdown, by Application
      • 10.2.6.4 Mexico: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.2.6.4.1 Mexico: In-Vitro Lung Model Market Breakdown, by Type
        • 10.2.6.4.2 Mexico: In-Vitro Lung Model Market Breakdown, by Application
        • 10.2.6.4.3 Mexico: In-Vitro Lung Model Market Breakdown, by End User
  • 10.3 Europe
    • 10.3.1 Europe In-Vitro Lung Model Market Overview
    • 10.3.2 Europe: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.3.3 Europe: In-Vitro Lung Model Market Breakdown, by Type
      • 10.3.3.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.3.4 Europe: In-Vitro Lung Model Market Breakdown, by Application
      • 10.3.4.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
    • 10.3.5 Europe: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.5.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.3.6 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.1 Europe: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.2 Germany: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.2.1 Germany: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.2.2 Germany: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.2.3 Germany: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.3 France: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.3.1 France: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.3.2 France: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.3.3 France: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.4 United Kingdom: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.4.1 United Kingdom: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.4.2 United Kingdom: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.4.3 United Kingdom: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.5 Italy: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.5.1 Italy: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.5.2 Italy: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.5.3 Italy: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.6 Spain: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.6.1 Spain: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.6.2 Spain: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.6.3 Spain: In-Vitro Lung Model Market Breakdown, by End User
      • 10.3.6.7 Rest of Europe: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.3.6.7.1 Rest of Europe: In-Vitro Lung Model Market Breakdown, by Type
        • 10.3.6.7.2 Rest of Europe: In-Vitro Lung Model Market Breakdown, by Application
        • 10.3.6.7.3 Rest of Europe: In-Vitro Lung Model Market Breakdown, by End User
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific In-Vitro Lung Model Market Overview
    • 10.4.2 Asia Pacific: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.4.3 Asia Pacific: In-Vitro Lung Model Market Breakdown, by Type
      • 10.4.3.1 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.4.4 Asia Pacific: In-Vitro Lung Model Market Breakdown, by Application
      • 10.4.4.1 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
      • 10.4.4.2 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.4.5 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.4.5.1 Asia Pacific: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.4.5.2 China: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.2.1 China: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.2.2 China: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.2.3 China: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.3 Japan: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.3.1 Japan: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.3.2 Japan: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.3.3 Japan: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.4 India: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.4.1 India: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.4.2 India: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.4.3 India: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.5 South Korea: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.5.1 South Korea: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.5.2 South Korea: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.5.3 South Korea: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.6 Australia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.6.1 Australia: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.6.2 Australia: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.6.3 Australia: In-Vitro Lung Model Market Breakdown, by End User
      • 10.4.5.7 Rest of APAC: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.4.5.7.1 Rest of APAC: In-Vitro Lung Model Market Breakdown, by Type
        • 10.4.5.7.2 Rest of APAC: In-Vitro Lung Model Market Breakdown, by Application
        • 10.4.5.7.3 Rest of APAC: In-Vitro Lung Model Market Breakdown, by End User
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa In-Vitro Lung Model Market Overview
    • 10.5.2 Middle East and Africa: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.5.3 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type
      • 10.5.3.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.5.4 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application
      • 10.5.4.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
    • 10.5.5 Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User
      • 10.5.5.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.5.6 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.1 Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.2 Saudi Arabia: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.2.1 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by Type
        • 10.5.6.2.2 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by Application
        • 10.5.6.2.3 Saudi Arabia: In-Vitro Lung Model Market Breakdown, by End User
      • 10.5.6.3 South Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.3.1 South Africa: In-Vitro Lung Model Market Breakdown, by Type
        • 10.5.6.3.2 South Africa: In-Vitro Lung Model Market Breakdown, by Application
        • 10.5.6.3.3 South Africa: In-Vitro Lung Model Market Breakdown, by End User
      • 10.5.6.4 United Arab Emirates: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.4.1 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by Type
        • 10.5.6.4.2 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by Application
        • 10.5.6.4.3 United Arab Emirates: In-Vitro Lung Model Market Breakdown, by End User
      • 10.5.6.5 Rest of Middle East and Africa: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.5.6.5.1 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Type
        • 10.5.6.5.2 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by Application
        • 10.5.6.5.3 Rest of Middle East and Africa: In-Vitro Lung Model Market Breakdown, by End User
  • 10.6 South and Central America
    • 10.6.1 South and Central America In-Vitro Lung Model Market Overview
    • 10.6.2 South and Central America: In-Vitro Lung Model Market - Revenue, 2021-2031 (US$ Million)
    • 10.6.3 South and Central America: In-Vitro Lung Model Market Breakdown, by Type
      • 10.6.3.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Type
    • 10.6.4 South and Central America: In-Vitro Lung Model Market Breakdown, by Application
      • 10.6.4.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Application
    • 10.6.5 South and Central America: In-Vitro Lung Model Market Breakdown, by End User
      • 10.6.5.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by End User
    • 10.6.6 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.1 South and Central America: In-Vitro Lung Model Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.2 Brazil: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.2.1 Brazil: In-Vitro Lung Model Market Breakdown, by Type
        • 10.6.6.2.2 Brazil: In-Vitro Lung Model Market Breakdown, by Application
        • 10.6.6.2.3 Brazil: In-Vitro Lung Model Market Breakdown, by End User
      • 10.6.6.3 Argentina: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.3.1 Argentina: In-Vitro Lung Model Market Breakdown, by Type
        • 10.6.6.3.2 Argentina: In-Vitro Lung Model Market Breakdown, by Application
        • 10.6.6.3.3 Argentina: In-Vitro Lung Model Market Breakdown, by End User
      • 10.6.6.4 Rest of South and Central America: In-Vitro Lung Model Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.6.6.4.1 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by Type
        • 10.6.6.4.2 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by Application
        • 10.6.6.4.3 Rest of South and Central America: In-Vitro Lung Model Market Breakdown, by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 New Product Development
  • 11.3 Merger and Acquisition
  • 11.4 Partnerships and Collaborations
  • 11.5 Other Business Strategies

12. Competitive Landscape

  • 12.1 Global Company Market Share Analysis, 2024

13. Company Profiles

  • 13.1 MatTek Corp
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Lonza Group AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Emulate, Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 CN Bio Innovations Ltd
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Merck KGaA
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 PromoCell GmbH
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
  • 13.7 Charles River Laboratories International Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 MIMETAS BV
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 InSphero AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Organovo Holdings Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Draper, Inc.
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 TissUse GmbH
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
  • 13.13 Epithelix
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Financial Overview
    • 13.13.4 SWOT Analysis
    • 13.13.5 Key Developments
  • 13.14 AlveoliX AG
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 American Type Culture Collection (ATCC)
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms